Alpha‐interferon (α‐IFN) protects B‐chronic lymphocytic leukaemia cells from apoptotic cell death in vitro
- 1 January 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 86 (1) , 169-173
- https://doi.org/10.1111/j.1365-2141.1994.tb03269.x
Abstract
B-chronic lymphocytic leukaemia cells (CLL) are prone to apoptotic cell death when cultured in vitro. Apoptosis and loss of the bcl-2 protein is prevented in CLL cells cultured in the presence of interleukin-4. In this study we analysed the effects of alpha-IFN on the DNA fragmentation, bcl-2 protein levels and cell survival in purified B-cells from 16 CLL patients. Alpha-IFN (10(3) U/ml) reduced the degree of spontaneous DNA fragmentation of CLL cells after a 30 h culture period (from a mean of 22.2% in control cultures to 10.5%, P < 0.01). This inhibition was accompanied by preservation of bcl-2 protein and an increased survival of CLL cells compared to control cultures. In parallel, alpha-IFN inhibited hydrocortisone induced DNA fragmentation in CLL cells. The effects of alpha-IFN on DNA synthesis of CLL cells were variable (in two patients a decrease and in seven an increase in 3H-thymidine uptake) and did not correlate with the effect on DNA fragmentation. In conclusion, our data suggest that alpha-IFN, like IL-4 and gamma-IFN, inhibits apoptosis of CLL cells. These in vitro data indicate that the clinical responses of some CLL patients to alpha-IFN cannot be explained by a direct cytotoxic effect of alpha-IFN on circulating CLL cells. Alternatively, alpha-IFN may inhibit the proliferation of the small fraction of clonogenic CLL progenitors, or interfere with cellular interactions necessary for the survival and growth of CLL cells.Keywords
This publication has 15 references indexed in Scilit:
- Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1993
- Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.The Journal of Experimental Medicine, 1992
- Bcl-2 initiates a new category of oncogenes: regulators of cell deathBlood, 1992
- All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatmentBlood, 1991
- B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLLBlood, 1991
- Interferon alfa‐2b therapy in untreated early stage, B‐chronic lymphocytic leukaemia patients: one‐year follow‐upBritish Journal of Haematology, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitroBritish Journal of Haematology, 1989
- TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIESThe Lancet, 1988
- Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitroBlood, 1986